Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis

NCT02183064 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1309

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: Meloxicam
DRUG: NSAID

Sponsor

Boehringer Ingelheim